Brendan Smith
Brendan Smith, PhD, is a Director and Senior Analyst covering Life Science Tools and Diagnostics equity research at TD Cowen. He holds a doctorate from Columbia University, conferred in 2018, and previously served as an Associate at Cowen & Co. LLC from 2019 to 2024. He is known for his analysis of the life science tools and diagnostics sector, including themes such as AI-driven drug discovery, bioprocessing, and pharmaceutical R&D spending trends.
“The hope is to 'create more shots on goal,' says Brendan Smith, director of life sciences equity research at TD Cowen, and to generate large amounts of data that can train the AI models to increase the odds of clinical success.”
Source→AI-extracted from podcast / newsletter / paper summaries. May contain errors.